Latest News by Industry
SAN DIEGO (AP) — SAN DIEGO (AP) — Kura Oncology Inc. (KURA) on Thursday reported a loss of $33.1 million in its fourth quarter.
On a per-share basis, the San Diego-based company said it had a loss of 49 cents.
The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 58 cents per share.
For the year, the company reported that its loss widened to $135.8 million, or $2.03 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a KURA">Zacks stock report on KURA at https://www.zacks.com/ap/KURA